Amarin Corp Plc (AMRN)

[HDGabor]

m-

united healthcare will no longer be covering Vascepa or generic Icosapent Ethyl for severe hypertriglyceridemia (Triglycerides >500). Instead they will cover generic Lovaza and/or Fibrates

To cancel the VHTG indication from the label is futile, the indication will exist independently from Vascepa ('s label) ... however modify the coverage agreements - terminate the VHTG part - is a brilliant step. Let's hope all HCP will do the same. (Assumping it is Amarin's action, plan going forward ... let the 10% of the market for the gV WITHOUT coverage.)

Best,
G